Enlivex Treasury Portfolio Update: RAIN Holdings Valued at Approximately $1.14 Billion
Rhea-AI Summary
Enlivex (Nasdaq: ENLV) reported updated treasury metrics tied to its RAIN token holdings. As of June 20, 2026, Enlivex held 79,568,550,005 RAIN tokens valued at approximately $1.14 billion. Treasury NAV per Share was $4.671, based on current RAIN holdings and ordinary shares outstanding.
Positive
- RAIN token holdings valued at approximately $1.14 billion as of June 20, 2026
- Treasury NAV per Share reported at $4.671 based on current RAIN holdings
- Transparent, unaudited mark-to-market treasury metrics available via public dashboard
Negative
- None.
News Market Reaction – ENLV
In the Jun 22 session, ENLV gained 0.21%, reflecting a mild positive market reaction. Argus tracked a peak move of +4.2% during that session. Argus tracked a trough of -12.2% from its starting point during tracking. Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jun 15 | Patent issuance | Positive | -1.5% | Australian patent granted for Allocetra use in osteoarthritis through at least 2040. |
| Jun 02 | Conference participation | Neutral | -1.6% | Gold sponsorship and model presentation at Proof of Talk 2026 investor-focused event. |
| Jun 01 | Clinical data update | Positive | +6.5% | Phase IIa Allocetra data showed durable, significant efficacy in knee osteoarthritis. |
| May 28 | Treasury/Rain update | Positive | -2.3% | RAIN holdings update plus new Rain advisory board and liquidity commitment. |
| May 27 | Treasury/Rain update | Positive | +14.3% | RAIN token holdings and option exposure as Rain entered top three by TVL. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent news shows mixed reactions, with some strong gains on RAIN/clinical updates but several positive items met with selling.
Key Terms
mark-to-market financial
prediction markets treasury financial
trading volume financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
- As of June 18, 2026, Enlivex held 79,568,550,005 RAIN tokens with a total value of approximately
$1.14 billion 1.
Nes-Ziona, Israel, June 22, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV, "Enlivex" or the "Company"), a quality longevity company powered by a prediction markets treasury, today provided an update on its RAIN token holdings. As of June 20, 2026, the Company held 79,568,550,005 RAIN tokens with a total value of approximately
The Company's treasury metrics, as reflected on its public market data dashboard, indicate a Treasury NAV per Share of
About Enlivex
Enlivex is a quality longevity company powered by a prediction markets treasury. The Company is advancing Allocetra™, an advanced clinical-stage immunotherapy targeting inflammatory conditions associated with aging, with a primary focus on age-related osteoarthritis. In addition to its clinical programs, Enlivex operates a prediction markets treasury strategy built around the Rain protocol, the leading decentralized prediction markets infrastructure on Arbitrum. This dual strategy combines the development of quality longevity therapeutics with exposure to the emerging prediction markets ecosystem.
Forward-looking statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements may be identified by words such as "expects," "plans," "projects," "will," "may," "anticipates," "believes," "should," "would," "could," "intends," "estimates," "suggests," "target," "has the potential to," "goal," and other words of similar meaning, including statements relating to the anticipated benefits of the Company's digital asset treasury strategy; the assets to be held by the Company; the expected future market, price, trading activity, and liquidity of the RAIN token; the impact of expanded exchange listings and increased token liquidity on market participation and accessibility; the potential effects of digital asset liquidity on the liquidity of the Company's ordinary shares; macroeconomic, political, and regulatory conditions surrounding digital assets; the Company's plans for value creation and strategic positioning; market size and growth opportunities; regulatory conditions; competitive position; technological and market trends; future financial condition and performance; expected clinical trial results; market opportunities for the results of current clinical studies and preclinical experiments; and the effectiveness of, and market opportunities for, ALLOCETRA™ programs.
Each forward-looking statement contained in this press release is subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statement. Applicable risks and uncertainties include, among others, the risk of failure to realize the anticipated benefits of the Company's digital asset treasury strategy; changes in business, market, financial, political, and regulatory conditions; risks relating to the Company's operations and business, including the highly volatile nature of the price, trading volume, and liquidity of RAIN and other cryptocurrencies; risks associated with digital asset exchange listings, trading venues, and market infrastructure; the risk that the price and liquidity of the Company's ordinary shares may be correlated with the price or liquidity of the digital assets it holds; risks related to increased competition in the industries in which the Company operates; risks relating to significant legal, commercial, regulatory, and technical uncertainty regarding digital assets generally; risks relating to the treatment of crypto assets for U.S. and foreign tax purposes; and those risks and uncertainties identified in the Company's filings with the Securities and Exchange Commission. The forward-looking statements in this press release speak only as of the date of this document, and the Company undertakes no obligation to update or revise any of these statements, except as required by applicable law.
Enlivex contact
Shachar Shlosberger
CFO
Enlivex Ltd.
shachar@enlivex.com
1 Valuation calculated using the closing price of the token as quoted on https://coinmarketcap.com/currencies/rain/
